Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggressive Albuminuria Reduction in Diabetic Nephropathy
NCT05897372Phase 2Terminated
- Start
- Aug 2023
- Primary completion
- Sep 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of semaglutide, pentoxifylline, hydrochlorothiazide, baricitinib in diabetic kidney disease (DKD). Started Aug 2023; status: terminated.
02
Drugs
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT05897372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05897372.